Evidence map›Paper›PMID 32733568›Full record

ArticleInternational journal of analytical chemistry2020

Prevalidation of an ELISA for Detection of a New Clinical Entity:

Bhagya Deepachandi, Sudath Weerasinghe, Himali Gunathilake, Thisira P Andrahennadi, Mahendra N Wickramanayake, Shantha Siri, Vishvanath Chandrasekharan, Preethi Soysa, Yamuna Siriwardana

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of analytical chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Diagnostic Tools for Cutaneous Leishmaniasis Caused byDiagnostics (Basel, Switzerland) · 2023
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Bhagya DeepachandiDepartment of Parasitology, Faculty of Medicine, University of Colombo, Colombo 00800, Sri Lanka.
Sudath WeerasingheDepartment of Parasitology, Faculty of Medicine, University of Colombo, Colombo 00800, Sri Lanka.
Himali GunathilakeDepartment of Parasitology, Faculty of Medicine, University of Colombo, Colombo 00800, Sri Lanka.
Thisira P AndrahennadiDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Colombo, Colombo 00800, Sri Lanka.
Mahendra N WickramanayakeDepartment of Chemistry, Faculty of Science, University of Colombo, Colombo 00300, Sri Lanka.
Shantha SiriNational Science Foundation, 47/5 Maitland Place, Colombo 00700, Sri Lanka.
Vishvanath ChandrasekharanDepartment of Chemistry, Faculty of Science, University of Colombo, Colombo 00300, Sri Lanka.
Preethi SoysaDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Colombo, Colombo 00800, Sri Lanka.
Yamuna SiriwardanaDepartment of Parasitology, Faculty of Medicine, University of Colombo, Colombo 00800, Sri Lanka.ORCID https://orcid.org/0000-0003-3283-0140
University of Colombo · LKNational Science Foundation of Sri Lanka · LK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human leishmaniasis which is considered a neglected tropical parasitic disease presents in three main clinical forms (i.e., cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral leishmaniasis (VL)) that are mainly determined by its causative species.

Identifiers

PMID32733568
PMCPMC7378632
OpenAlexW3043395248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.